Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Change in Acquisitions & Divestments (2017 - 2022)

Historic Change in Acquisitions & Divestments for Iterum Therapeutics (ITRM) over the last 5 years, with Q4 2022 value amounting to $14.1 million.

  • Iterum Therapeutics' Change in Acquisitions & Divestments rose 46400.0% to $14.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $59.7 million, marking a year-over-year increase of 69371.43%. This contributed to the annual value of $30.6 million for FY2024, which is 5257.87% down from last year.
  • Per Iterum Therapeutics' latest filing, its Change in Acquisitions & Divestments stood at $14.1 million for Q4 2022, which was up 46400.0% from $17.0 million recorded in Q3 2022.
  • Over the past 5 years, Iterum Therapeutics' Change in Acquisitions & Divestments peaked at $36.5 million during Q4 2018, and registered a low of $25000.0 during Q3 2019.
  • For the 4-year period, Iterum Therapeutics' Change in Acquisitions & Divestments averaged around $15.9 million, with its median value being $16.4 million (2018).
  • As far as peak fluctuations go, Iterum Therapeutics' Change in Acquisitions & Divestments tumbled by 9985.51% in 2019, and later skyrocketed by 46400.0% in 2022.
  • Iterum Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $36.5 million in 2018, then plummeted by 99.93% to $25000.0 in 2019, then soared by 9900.0% to $2.5 million in 2021, then soared by 464.0% to $14.1 million in 2022.
  • Its Change in Acquisitions & Divestments stands at $14.1 million for Q4 2022, versus $17.0 million for Q3 2022 and $7.7 million for Q2 2022.